Monday, December 04, 2023 7:58:31 PM
https://finance.yahoo.com/news/chris-ryan-becomes-ceo-cancer-123000944.html
ACCESSWIRE
This is public knowledge that the same person doxing everyone, pants on fire…. Is actually connected to the same people. And CEO!
January 6, 2016
RENO, NV / ACCESSWIRE / January 6, 2016 / Cancer.im, Inc. a Viratech Corp. Company (VIRA) announced today that Chris Ryan has been appointed as the new CEO of Cancer.im, Inc., a for profit social network resource site for cancer patients, survivors, advocates, and caretakers.
"Chris Ryan has a unique skill set and razor focused vision. His goal for the last 10 years, has been to change the way people view and manage cancer," stated Fred Schiemann CEO of Viratech.
He has an extensive background in business development, investment banking, regulatory compliance and biotech incubation. Including but not limited to; IND's, Phase 1, Phase 2, Orphan Drug Act, Phase 3 and PMA compliance.
An advocate for open source biotech research, Mr. Ryan is an 8 time bestselling author on the subjects of cancer, cellular metabolism and bioinformatics. His work in cancer research has won the endorsements and praise of thought leaders throughout the world including; Jack Canfield (Chicken Soup of the Soul), Dr. Barkat Charania (SINA Foundation), and Tommy Thompson, (former United States Secretary of Health and Human Services.
On October 27, 2007 Dr. Nikolaou, on behalf of Fox Chase Medical Center published a double blind placebo controlled study titled "Quality of Life (QOL) Supersedes the Classic Predictors of Survival in Locally Advanced Non-Small Cell Lung Cancer (NSCLC) ". This study concluded that by raising a Cancer Patients Quality of Life via the European Organization for Research and Treatment of Cancer (EORTC QLQ-C30 index), you could directly lower the incidence of morbidity in a cancer patient, regardless of treatment.
In 2008, Chris Ryan with Oncologist Dr. Mahesh Kanojia, Dr. Barkat Charania, and Dr. Kevin Buckman adapted the above referenced study into a modular 15 part best practice navigation element, and guide on teaching and assisting cancer patients in raising their Quality of Life.
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM